Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE (WBA)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Walgreens Boots Alliance : Sales Growth Falls Short--Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 02:33pm CEST

By Kimberly Chin

Walgreens Boots Alliance Inc.'s shares slid in premarket trading as weaker sales of non-pharmacy items put a damper on the drugstore chain's sales growth.

Comparable retail sales in the fourth quarter fell 1.9% from a year earlier in the U.S., weighed by less demand in the general-merchandise and personal-care categories. Comparable retail sales in its international segment fell 0.9% on a constant-currency basis.

Overall sales rose 11% to $33.44 billion, as growth in prescription volumes helped lift pharmacy sales. Walgreens said U.S. pharmacy sales rose 17%, due primarily to its acquisition of stores from Rite Aid Corp. Thursday, the company said the integration remains on track and has helped it gain market share. Analysts had expected Walgreens to report $33.78 billion in revenue, according to a Refinitiv poll.

Shares fell 2.5% to $70.51. Walgreens stock has been flat for the year.

Net income for the Deerfield, Ill.-based company rose 89% to $1.51 billion, or $1.55 a share, from the same period a year ago. On an adjusted basis, earnings per share came in at $1.48, above the $1.45 expected by analysts.

The drugstore chain also gave earnings guidance for the fiscal year 2019. It expects earnings growth between 7% to 12% at constant-currency rates, and adjusted earnings per share in the range of $6.40 to $6.70. Analysts expect adjusted earnings of $6.45 a share.

The company, whose roots date to 1901, has more than 18,500 stores across 11 countries.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
RITE AID CORPORATION -1.87% 1.05 Delayed Quote.-46.19%
WALGREENS BOOTS ALLIANCE -0.52% 76.58 Delayed Quote.1.21%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
10/18WALGREENS BOOTS ALLIANCE : and McLaren Health Care Announce Health Services and ..
AQ
10/17WALGREENS BOOTS ALLIANCE : McLaren Health to Collaborate on Health Care, Pharmac..
DJ
10/17WALGREENS BOOTS ALLIANCE : and McLaren Health Care Announce Health Services and ..
PR
10/12RITE AID : Deal Lifts Walgreens Pharmacy
DJ
10/11WALGREENS BOOTS ALLIANCE : Management's discussion and analysis of financial con..
AQ
10/11WALGREENS BOOTS ALLIANCE : Sales Growth Falls Short -- 2nd Update
DJ
10/11LABORATORY OF AMERICA : Walgreens and LabCorp to Open at Least 600 LabCorp at Wa..
AQ
10/11WALGREENS BOOTS ALLIANCE : Sales Growth Falls Short--Update
DJ
10/11WALGREENS BOOTS ALLIANCE : Reports Soaring Profit But Sales Miss Expectations
DJ
10/11WALGREENS BOOTS ALLIANCE : tops 4Q expectations, helped by Rite Aid deal
AQ
More news
News from SeekingAlpha
10/182018 Third Quarter Review - Buying Dividend Growth Stocks Without Looking 
10/18GW Pharma Pipeline Will Add To Bottom Line And Stock Price 
10/16AmerisourceBergen perks up on chance of WBA deal; shares up 4% 
10/16Beat The Recession With Dividends - Part 3 
10/16Jerry Maguire Stock Market 
Financials ($)
Sales 2019 138 B
EBIT 2019 7 993 M
Net income 2019 5 450 M
Debt 2019 12 869 M
Yield 2019 2,27%
P/E ratio 2019 13,33
P/E ratio 2020 12,09
EV / Sales 2019 0,62x
EV / Sales 2020 0,59x
Capitalization 73 067 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 76,8 $
Spread / Average Target -0,27%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
Alexander W. Gourlay President & Co-Chief Operating Officer
Richard M. Ashworth President-Operations
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE1.21%73 067
EXPRESS SCRIPTS HOLDING CO25.29%53 834
MCKESSON CORPORATION-15.76%26 977
AMERISOURCEBERGEN-2.48%20 286
CARDINAL HEALTH-15.73%16 049
WELCIA HOLDINGS CO LTD24.90%5 499